Plexus Announces Fiscal Second Quarter Financial Results
- None.
- None.
NEENAH, WI, April 24, 2024 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 30, 2024, and guidance for our fiscal third quarter ending June 29, 2024.
- Reports fiscal second quarter 2024 revenue of
$967 million , GAAP operating margin of3.0% and GAAP diluted EPS of$0.58 , including$0.25 of stock-based compensation expense and$0.36 of restructuring and other charges, net - Reports fiscal second quarter 2024 non-GAAP operating margin of
4.2% and non-GAAP diluted EPS of$0.94 , including$0.25 of stock-based compensation expense - Initiates fiscal third quarter 2024 revenue guidance of
$960 million to$1.00 billion with GAAP diluted EPS of$0.80 t o$0.95 , including$0.21 of stock-based compensation expense and$0.21 of restructuring charges. Fiscal third quarter 2024 non-GAAP EPS guidance of$1.22 t o$1.37 excludes both stock-based compensation expense and restructuring charges.
Three Months Ended | |||||||
Mar 30, 2024 | Mar 30, 2024 | Jun 29, 2024 | |||||
Q2F24 Results | Q2F24 Guidance | Q3F24 Guidance (1) | |||||
Summary GAAP Items | |||||||
Revenue (in millions) | |||||||
Operating margin (2) | 3.0 | % | |||||
Diluted EPS (3) | |||||||
Summary Non-GAAP Items (4) | |||||||
Adjusted operating margin (5) | 4.2 | % | |||||
Adjusted EPS (6) | |||||||
Adjusted operating margin, prospectively (7) | |||||||
Adjusted EPS, prospectively (8) | |||||||
Return on invested capital (ROIC) | 9.9 | % | |||||
Economic return | 1.7 | % | |||||
(1) | Historically, Plexus has included stock-based compensation expense in adjusted operating margin and adjusted EPS. Beginning in the fiscal third quarter, Plexus will issue guidance and present adjusted operating margin and adjusted EPS excluding stock-based compensation expense. Refer to the Non-GAAP Supplemental Information Table 3 for a reconciliation between the historic presentation and prospective presentation. | ||||||
(2) | Includes restructuring and other charges, net, of 120 bps for Q2F24 results, 100 bps for Q2F24 guidance and 70 bps for Q3F24 guidance. Includes stock-based compensation expense of 73 bps for Q2F24 results, 72 bps for Q2F24 guidance and 60 bps for Q3F24 guidance. | ||||||
(3) | Includes stock-based compensation expense of | ||||||
(4) | Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for additional information regarding non-GAAP financial measures. | ||||||
(5) | Excludes restructuring and other charges, net, of 120 bps for Q2F24 results and 100 bps for Q2F24 guidance. Excludes stock-based compensation expense of 73 bps for Q2F24 results and 72 bps for Q2F24 guidance. | ||||||
(6) | Q2F24 results excludes, net of tax, | ||||||
(7) | Excludes 70 bps for restructuring charges and 60 bps related to stock-based compensation expense. | ||||||
(8) | Excludes | ||||||
Fiscal Second Quarter 2024 Information
- Won 32 manufacturing programs during the quarter representing
$255 million in annualized revenue when fully ramped into production. - Purchased
$17.6 million of our shares at an average price of$94.39 per share under our repurchase programs, leaving$38.1 million available under our current$50.0 million authorization.
Todd Kelsey, Chief Executive Officer, commented, “Plexus delivered fiscal second quarter revenue of
Mr. Kelsey continued, “For the fiscal second quarter, our team won 32 new manufacturing programs worth
Mr. Kelsey commented, “We are guiding fiscal third quarter revenue of
Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “The
Mr. Kelsey concluded, “We continue to anticipate a strong finish to fiscal 2024 with expansion in revenue and non-GAAP operating margin each quarter as well as robust free cash flow generation, positioning us for further momentum into fiscal 2025. Supporting this outlook is the previously highlighted strength in certain market sectors and subsectors, new program ramps, improving utilization of our engineering team and the benefits from recent restructuring actions.”
Quarterly Comparison | Three Months Ended | ||||||||||
(in thousands, except EPS) | Mar 30, 2024 | Dec 30, 2023 | Apr 1, 2023 | ||||||||
Revenue | $ | 966,900 | $ | 982,607 | $ | 1,070,823 | |||||
Gross profit | 88,063 | 88,140 | 102,993 | ||||||||
Operating income | 29,470 | 45,158 | 56,942 | ||||||||
Net income | 16,239 | 29,215 | 40,844 | ||||||||
Diluted EPS | $ | 0.58 | $ | 1.04 | $ | 1.45 | |||||
Gross margin | 9.1 | % | 9.0 | % | 9.6 | % | |||||
Operating margin | 3.0 | % | 4.6 | % | 5.3 | % | |||||
ROIC (1) | 9.9 | % | 10.3 | % | 13.8 | % | |||||
Economic return (1) | 1.7 | % | 2.1 | % | 4.8 | % | |||||
(1) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. | |||||||||||
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised
Business Segments ($ in millions) | Three Months Ended | ||||||||||
Mar 30, 2024 | Dec 30, 2023 | Apr 1, 2023 | |||||||||
Americas | $ | 322 | $ | 334 | $ | 408 | |||||
Asia-Pacific | 521 | 552 | 587 | ||||||||
Europe, Middle East and Africa | 155 | 122 | 102 | ||||||||
Elimination of inter-segment sales | (31 | ) | (25 | ) | (26 | ) | |||||
Total Revenue | $ | 967 | $ | 983 | $ | 1,071 | |||||
Market Sectors ($ in millions) | Three Months Ended | |||||||||||||
Mar 30, 2024 | Dec 30, 2023 | Apr 1, 2023 | ||||||||||||
Healthcare/Life Sciences | $ | 379 | 39 | % | $ | 381 | 39 | % | $ | 488 | 46 | % | ||
Industrial | 418 | 43 | % | 435 | 44 | % | 439 | 41 | % | |||||
Aerospace/Defense | 170 | 18 | % | 167 | 17 | % | 144 | 13 | % | |||||
Total Revenue | $ | 967 | $ | 983 | $ | 1,071 | ||||||||
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for the second quarter of fiscal 2024 was
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended March 30, 2024, cash flows provided by operations were
Cash Cycle Days | Three Months Ended | |||||
Mar 30, 2024 | Dec 30, 2023 | Apr 1, 2023 | ||||
Days in Accounts Receivable | 61 | 61 | 56 | |||
Days in Contract Assets | 12 | 12 | 11 | |||
Days in Inventory | 158 | 161 | 156 | |||
Days in Accounts Payable | (65) | (66) | (69) | |||
Days in Advanced Payments (1) | (75) | (73) | (72) | |||
Annualized Cash Cycle (2) | 91 | 95 | 82 | |||
(1) | Includes a reclassification in the presentation of advanced payments from customers reflected in prior period amounts. As of April 1, 2023, the impact of this reclassification was an increase in the Company's days in advanced payments and a reduction in annualized cash cycle by 22 days. | |||||
(2) | Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments. | |||||
Conference Call and Webcast Information
What: | Plexus Fiscal 2024 Q2 Earnings Conference Call and Webcast |
When: | Thursday, April 25, 2024 at 8:30 a.m. Eastern Time |
Where: | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Audio conferencing link: https://register.vevent.com/register/BI408fb95be3e440b981d3e0808adddf91 Webcast link: https://edge.media-server.com/mmc/p/wrgz2xex |
Replay: | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
Since 1979, Plexus has been partnering with companies to create the products that build a better world. We are a team of over 20,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. Plexus is a global leader that specializes in serving customers in industries with highly complex products and demanding regulatory environments. Plexus delivers customer service excellence to leading companies by providing innovative, comprehensive solutions throughout a product’s lifecycle. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2023 Form 10-K.
PLEXUS CORP. AND SUBSIDIARIES | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(in thousands, except per share data) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||
Mar 30, | Apr 1, | Mar 30, | Apr 1, | ||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Net sales | $ | 966,900 | $ | 1,070,823 | $ | 1,949,507 | $ | 2,164,748 | |||||||
Cost of sales | 878,837 | 967,830 | 1,773,304 | 1,960,556 | |||||||||||
Gross profit | 88,063 | 102,993 | 176,203 | 204,192 | |||||||||||
Operating expenses: | |||||||||||||||
Selling and administrative expenses | 47,555 | 46,051 | 90,537 | 89,909 | |||||||||||
Restructuring and other charges, net | 11,038 | — | 11,038 | — | |||||||||||
Operating income | 29,470 | 56,942 | 74,628 | 114,283 | |||||||||||
Other income (expense): | |||||||||||||||
Interest expense | (8,293 | ) | (8,287 | ) | (15,910 | ) | (15,181 | ) | |||||||
Interest income | 817 | 759 | 1,625 | 1,693 | |||||||||||
Miscellaneous, net | (3,027 | ) | (1,612 | ) | (6,529 | ) | (3,556 | ) | |||||||
Income before income taxes | 18,967 | 47,802 | 53,814 | 97,239 | |||||||||||
Income tax expense | 2,728 | 6,958 | 8,360 | 14,205 | |||||||||||
Net income | $ | 16,239 | $ | 40,844 | $ | 45,454 | $ | 83,034 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 0.59 | $ | 1.48 | $ | 1.65 | $ | 3.00 | |||||||
Diluted | $ | 0.58 | $ | 1.45 | $ | 1.62 | $ | 2.94 | |||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 27,542 | 27,661 | 27,513 | 27,650 | |||||||||||
Diluted | 27,929 | 28,184 | 27,982 | 28,273 | |||||||||||
PLEXUS CORP. AND SUBSIDIARIES | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(in thousands, except per share data) | |||||||
(unaudited) | |||||||
Mar 30, | Sep 30, | ||||||
2024 | 2023 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 265,053 | $ | 256,233 | |||
Restricted cash | 41 | 421 | |||||
Accounts receivable | 645,523 | 661,542 | |||||
Contract assets | 131,174 | 142,297 | |||||
Inventories | 1,518,729 | 1,562,037 | |||||
Prepaid expenses and other | 70,531 | 49,693 | |||||
Total current assets | 2,631,051 | 2,672,223 | |||||
Property, plant and equipment, net | 493,803 | 492,036 | |||||
Operating lease right-of-use assets | 63,106 | 69,363 | |||||
Deferred income taxes | 62,665 | 62,590 | |||||
Other assets | 26,032 | 24,960 | |||||
Total non-current assets | 645,606 | 648,949 | |||||
Total assets | $ | 3,276,657 | $ | 3,321,172 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Current portion of long-term debt and finance lease obligations | $ | 245,964 | $ | 240,205 | |||
Accounts payable | 627,427 | 646,610 | |||||
Advanced payments from customers | 716,172 | 760,351 | |||||
Accrued salaries and wages | 72,880 | 94,099 | |||||
Other accrued liabilities | 74,392 | 71,402 | |||||
Total current liabilities | 1,736,835 | 1,812,667 | |||||
Long-term debt and finance lease obligations, net of current portion | 192,025 | 190,853 | |||||
Accrued income taxes payable | 17,198 | 31,382 | |||||
Long-term operating lease liabilities | 33,915 | 38,552 | |||||
Deferred income taxes | 4,429 | 4,350 | |||||
Other liabilities | 32,493 | 28,986 | |||||
Total non-current liabilities | 280,060 | 294,123 | |||||
Total liabilities | 2,016,895 | 2,106,790 | |||||
Shareholders’ equity: | |||||||
Common stock | 545 | 543 | |||||
Additional paid-in-capital | 663,130 | 661,270 | |||||
Common stock held in treasury | (1,151,997 | ) | (1,134,429 | ) | |||
Retained earnings | 1,756,782 | 1,711,328 | |||||
Accumulated other comprehensive loss | (8,698 | ) | (24,330 | ) | |||
Total shareholders’ equity | 1,259,762 | 1,214,382 | |||||
Total liabilities and shareholders’ equity | $ | 3,276,657 | $ | 3,321,172 | |||
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 1 | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
Mar 30, | Dec 30, | Apr 1, | Mar 30, | Apr 1, | ||||||||||||||||
2024 | 2023 | 2023 | 2024 | 2023 | ||||||||||||||||
Operating income, as reported | $ | 29,470 | $ | 45,158 | $ | 56,942 | $ | 74,628 | $ | 114,283 | ||||||||||
Operating margin, as reported | 3.0 | % | 4.6 | % | 5.3 | % | 3.8 | % | 5.3 | % | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring costs (1) | 13,288 | — | — | 13,288 | — | |||||||||||||||
Other non-recurring income (2) | (2,250 | ) | — | — | (2,250 | ) | — | |||||||||||||
Non-GAAP operating income | $ | 40,508 | $ | 45,158 | $ | 56,942 | $ | 85,666 | $ | 114,283 | ||||||||||
Non-GAAP operating margin | 4.2 | % | 4.6 | % | 5.3 | % | 4.4 | % | 5.3 | % | ||||||||||
Net income, as reported | $ | 16,239 | $ | 29,215 | $ | 40,844 | $ | 45,454 | $ | 83,034 | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring costs, net of tax (1) | 11,893 | — | — | 11,893 | — | |||||||||||||||
Other non-recurring income, net of tax (2) | (2,014 | ) | — | — | (2,014 | ) | — | |||||||||||||
Adjusted net income | $ | 26,118 | $ | 29,215 | $ | 40,844 | $ | 55,333 | $ | 83,034 | ||||||||||
Diluted earnings per share, as reported | $ | 0.58 | $ | 1.04 | $ | 1.45 | $ | 1.62 | $ | 2.94 | ||||||||||
Non-GAAP per share adjustments: | ||||||||||||||||||||
Restructuring costs, net of tax (1) | 0.43 | — | — | 0.43 | — | |||||||||||||||
Other non-recurring income, net of tax (2) | (0.07 | ) | — | — | (0.07 | ) | — | |||||||||||||
Adjusted diluted earnings per share | $ | 0.94 | $ | 1.04 | $ | 1.45 | $ | 1.98 | $ | 2.94 | ||||||||||
(1) | During the three and six months ended March 30, 2024, restructuring and impairment charges of | |||||||||||||||||||
(2) | During the three and six months ended March 30, 2024, insurance proceeds of | |||||||||||||||||||
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 2 | ||||||||||||||
(in thousands) | ||||||||||||||
(unaudited) | ||||||||||||||
ROIC and Economic Return Calculations | Six Months Ended | Three Months Ended | Six Months Ended | |||||||||||
Mar 30, | Dec 30, | Apr 1, | ||||||||||||
2024 | 2023 | 2023 | ||||||||||||
Operating income, as reported | $ | 74,628 | $ | 45,158 | $ | 114,283 | ||||||||
Restructuring and other charges, net | + | 11,038 | + | — | + | — | ||||||||
Adjusted operating income | $ | 85,666 | $ | 45,158 | $ | 114,283 | ||||||||
x | 2 | x | 4 | x | 2 | |||||||||
Adjusted annualized operating income | $ | 171,332 | $ | 180,632 | $ | 228,566 | ||||||||
Adjusted effective tax rate | x | 15 | % | x | 16 | % | x | 15 | % | |||||
Tax impact | 25,700 | 28,901 | 34,285 | |||||||||||
Adjusted operating income (tax-effected) | $ | 145,632 | $ | 151,731 | $ | 194,281 | ||||||||
Average invested capital | ÷ | $ | 1,478,062 | ÷ | $ | 1,479,647 | ÷ | $ | 1,406,359 | |||||
ROIC | 9.9 | % | 10.3 | % | 13.8 | % | ||||||||
Weighted average cost of capital | - | 8.2 | % | - | 8.2 | % | - | 9.0 | % | |||||
Economic return | 1.7 | % | 2.1 | % | 4.8 | % | ||||||||
Average Invested Capital Calculations | Mar 30, | Dec 30, | Sep 30, | Jul 1, | Apr 1, | Dec 31, | Oct 1, | ||||||||||||||||||||
2024 | 2023 | 2023 | 2023 | 2023 | 2022 | 2022 | |||||||||||||||||||||
Equity | $ | 1,259,762 | $ | 1,266,755 | $ | 1,214,382 | $ | 1,184,362 | $ | 1,182,382 | $ | 1,150,259 | $ | 1,095,731 | |||||||||||||
Plus: | |||||||||||||||||||||||||||
Debt and finance lease obligations - current | 245,964 | 251,119 | 240,205 | 304,781 | 294,011 | 329,076 | 273,971 | ||||||||||||||||||||
Operating lease obligations - current (1) | 8,281 | 9,172 | 8,363 | 8,772 | 8,358 | 8,878 | 7,948 | ||||||||||||||||||||
Debt and finance lease obligations - long-term | 192,025 | 192,118 | 190,853 | 187,468 | 188,730 | 187,272 | 187,776 | ||||||||||||||||||||
Operating lease obligations - long-term | 33,915 | 35,989 | 38,552 | 40,515 | 31,257 | 32,149 | 33,628 | ||||||||||||||||||||
Less: | |||||||||||||||||||||||||||
Cash and cash equivalents | (265,053 | ) | (231,982 | ) | (256,233 | ) | (252,965 | ) | (269,664 | ) | (247,880 | ) | (274,805 | ) | |||||||||||||
$ | 1,474,894 | $ | 1,523,171 | $ | 1,436,122 | $ | 1,472,933 | $ | 1,435,074 | $ | 1,459,754 | $ | 1,324,249 | ||||||||||||||
(1) | Included in other accrued liabilities on the Condensed Consolidated Balance Sheets. | |
PLEXUS CORP. AND SUBSIDIARIES | |||||||||||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 3 | |||||||||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||||||||
(unaudited) | |||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
Dec 31, | Apr 1, | Jul 1, | Sep 30, | Dec 30, | Mar 30, | ||||||||||||||||||
2022 | 2023 | 2023 | 2023 | 2023 | 2024 | ||||||||||||||||||
Net sales | $ | 1,093,925 | $ | 1,070,823 | $ | 1,021,610 | $ | 1,023,947 | $ | 982,607 | $ | 966,900 | |||||||||||
Operating income, as reported | 57,341 | 56,942 | 28,204 | 53,333 | 45,158 | 29,470 | |||||||||||||||||
Operating margin, as reported | 5.2 | % | 5.3 | % | 2.8 | % | 5.2 | % | 4.6 | % | 3.0 | % | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Restructuring costs | — | — | 8,865 | — | — | 13,288 | |||||||||||||||||
Other non-recurring charges, net of tax | — | — | 14,229 | — | — | (2,250 | ) | ||||||||||||||||
Non-GAAP operating income, previously reported | 57,341 | 56,942 | 51,298 | 53,333 | 45,158 | 40,508 | |||||||||||||||||
Non-GAAP operating margin, previously reported | 5.2 | % | 5.3 | % | 5.0 | % | 5.2 | % | 4.6 | % | 4.2 | % | |||||||||||
Stock-based compensation | 5,819 | 5,907 | 3,829 | 5,824 | 5,335 | 7,096 | |||||||||||||||||
Non-GAAP operating income | $ | 63,160 | $ | 62,849 | $ | 55,127 | $ | 59,157 | $ | 50,493 | $ | 47,604 | |||||||||||
Non-GAAP operating margin | 5.8 | % | 5.9 | % | 5.4 | % | 5.8 | % | 5.1 | % | 4.9 | % | |||||||||||
Net income, as reported | $ | 42,190 | $ | 40,844 | $ | 15,799 | $ | 40,261 | $ | 29,215 | $ | 16,239 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Restructuring costs, net of tax | — | — | 7,920 | — | — | 11,893 | |||||||||||||||||
Other non-recurring charges, net of tax | — | — | 13,346 | — | — | (2,014 | ) | ||||||||||||||||
Adjusted net income, previously reported | 42,190 | 40,844 | 37,065 | 40,261 | 29,215 | 26,118 | |||||||||||||||||
Stock-based compensation | 5,819 | 5,907 | 3,829 | 5,824 | 5,335 | 7,096 | |||||||||||||||||
Adjusted net income | $ | 48,009 | $ | 46,751 | $ | 40,894 | $ | 46,085 | $ | 34,550 | $ | 33,214 | |||||||||||
Diluted weighted average shares outstanding | 28,305 | 28,184 | 27,992 | 27,972 | 28,013 | 27,929 | |||||||||||||||||
Diluted earnings per share, as previously reported | $ | 1.49 | $ | 1.45 | $ | 0.56 | $ | 1.44 | $ | 1.04 | $ | 0.58 | |||||||||||
Non-GAAP per share adjustments: | |||||||||||||||||||||||
Restructuring costs, net of tax | — | — | 0.28 | — | — | 0.43 | |||||||||||||||||
Other non-recurring charges, net of tax | — | — | 0.48 | — | — | (0.07 | ) | ||||||||||||||||
Adjusted diluted earnings per share, previously reported | 1.49 | 1.45 | 1.32 | 1.44 | 1.04 | 0.94 | |||||||||||||||||
Stock-based compensation | 0.21 | 0.21 | 0.14 | 0.21 | 0.19 | 0.25 | |||||||||||||||||
Adjusted diluted earnings per share | $ | 1.70 | $ | 1.66 | $ | 1.46 | $ | 1.65 | $ | 1.23 | $ | 1.19 | |||||||||||
FAQ
What is Plexus Corp.'s ticker symbol?
What was Plexus Corp.'s revenue in the fiscal second quarter of 2024?
What was Plexus Corp.'s GAAP operating margin in the fiscal second quarter of 2024?
What was Plexus Corp.'s GAAP diluted EPS in the fiscal second quarter of 2024?
What was Plexus Corp.'s non-GAAP operating margin in the fiscal second quarter of 2024?
What was Plexus Corp.'s non-GAAP diluted EPS in the fiscal second quarter of 2024?
What was Plexus Corp.'s return on invested capital (ROIC) in the fiscal second quarter of 2024?
What was Plexus Corp.'s economic return in the fiscal second quarter of 2024?
How many manufacturing programs did Plexus Corp. win in the fiscal second quarter of 2024?